VJHemOnc is committed to improving our service to you

ISAL 2019 | Acute leukemias: the doubled-edged sword of genetic complexity

VJHemOnc is committed to improving our service to you

Tariq Mughal

Acute leukemias are genetically heterogeneous, making their targeted therapy more complex. We spoke to Tariq Mughal, MD, MB, BS, MRCS, MRCP, FRCP, of Tufts University School of Medicine, Boston, MA, about our understanding of the genetic complexity of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). This interview took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter